National data-sharing task force appoints chair

Alan Hutson, PhD, a biostatistician at the Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center, was named to a four-year term as the chair of the Society for Immunotherapy of Cancer’s Data Sharing and Big Data Task Force.

Advertisement

Dr. Hutson is a professor of oncology within and chair of Roswell Park’s department of biostatistics and bioinformatics. In this new role, he will lead the task force’s efforts to address challenges associated with the accessibility and use of large datasets in developing immune-based cancer treatments.

“Some of the most exciting advances in cancer treatment of the last few years involved immunotherapies, but there’s so much untapped potential,” he said in a statement. “Our goal with this SITC Task Force and a lot of the work we do every day at Roswell Park is to assess what the most pressing priorities are in data utilization and management, and then address those challenges and opportunities so we can support the biggest oncology advances of the next decade.”

More articles on data analytics:
Prudential acquires analytics-driven insurtech startup Assurance for $2.4B
Cloudera acquires AI analytics firm Arcadia Data
Deloitte: Healthcare lagging in data modernization efforts

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.